IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Psyence Biomedical LTD

CUSIP: 74449F308 | 9 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DPsyence Labs Ltd.1,146,15930.1%New 5%+ stakeFeb 25, 2026No 13F filer matched
13D/AKaos Capital Ltd.313,8764.9%UnchangedJan 8, 2026

Institutional Holders — Q4 2025

Virtu Financial LLC37,042
0.0% of portfolio›$28
Bank of America Corp3,346
0.0% of portfolio›$2.5K
UBS Group AG1,007
0.0% of portfolio›$758
Stonehage Fleming Financial Services Holdings Ltd561
0.0% of portfolio›$422
StyleTurnoverLocationFiled
Virtu Financial LLC
37,042$280.0%GARPVery HighNew York, NY2026-02-23
Bank of America Corp
3,346$2.5K0.0%CoreLowCharlotte, NC2026-02-17
UBS Group AG
1,007$7580.0%CoreMediumZurich, Switzerland2026-01-29
Stonehage Fleming Financial Services Holdings Ltd
561$4220.0%GrowthMediumSt. Helier, Venezuela2026-01-13
No 13F filer matched
13DPsyence Labs Ltd.1,146,159
30.1% of class · Feb 25, 2026New 5%+ stake
No 13F filer matched
13D/AKaos Capital Ltd.313,876
4.9% of class · Jan 8, 2026Unchanged
No 13F filer matched